About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Tg(Lck-Notch3)#Issc
transgene insertion, Isabella Screpanti
MGI:4843437
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cx1
Prkcqtm1Litt/Prkcqtm1Litt
Tg(Lck-Notch3)#Issc/0
involves: 129P2/OlaHsd * C57BL/6 * DBA/2 MGI:4843446
tg2
Tg(Lck-Notch3)#Issc/0 involves: C57BL/6 * DBA/2 MGI:4843447


Genotype
MGI:4843446
cx1
Allelic
Composition
Prkcqtm1Litt/Prkcqtm1Litt
Tg(Lck-Notch3)#Issc/0
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6 * DBA/2
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Prkcqtm1Litt mutation (1 available); any Prkcq mutation (5 available)
Tg(Lck-Notch3)#Issc mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• compared with Tg(lck-Notch3)#Issc mice (J:96010)
• compared with Tg(lck-Notch3)#Issc mice (J:96010)
• 35% of mice die prior to 20 weeks of age (J:96010)
• of mice that survive beyond 20 weeks, 50% die over 30 weeks of age and 20% survive at 50 weeks of age (J:96010)
• 35% of mice die prior to 20 weeks of age (J:96010)
• of mice that survive beyond 20 weeks, 50% die over 30 weeks of age and 20% survive at 50 weeks of age (J:96010)

tumorigenesis
• 40% of mice that survive beyond 20 weeks of age exhibit lymphoproliferative disease (enlarged upper mediastium and 2- to 3-fold increase in spleen size and weight) compared with 95% of Tg(lck-Notch3)#Issc mice (J:96010)
• 40% of mice that survive beyond 20 weeks of age exhibit lymphoproliferative disease (enlarged upper mediastium and 2- to 3-fold increase in spleen size and weight) compared with 95% of Tg(lck-Notch3)#Issc mice (J:96010)

immune system
• 2- to 3-fold in 40% of mice that survive beyond 20 weeks of age (J:96010)
• 2- to 3-fold in 40% of mice that survive beyond 20 weeks of age (J:96010)
• 2- to 3-fold in 40% of mice that survive beyond 20 weeks of age (J:96010)
• 2- to 3-fold in 40% of mice that survive beyond 20 weeks of age (J:96010)

growth/size/body
• 40% of mice that survive beyond 20 weeks of age exhibit enlarged upper mediastium compared with wild-type mice (J:96010)
• 40% of mice that survive beyond 20 weeks of age exhibit enlarged upper mediastium compared with wild-type mice (J:96010)

hematopoietic system
• 2- to 3-fold in 40% of mice that survive beyond 20 weeks of age (J:96010)
• 2- to 3-fold in 40% of mice that survive beyond 20 weeks of age (J:96010)
• 2- to 3-fold in 40% of mice that survive beyond 20 weeks of age (J:96010)
• 2- to 3-fold in 40% of mice that survive beyond 20 weeks of age (J:96010)




Genotype
MGI:4843447
tg2
Allelic
Composition
Tg(Lck-Notch3)#Issc/0
Genetic
Background
involves: C57BL/6 * DBA/2
Find Mice Using the International Mouse Strain Resource (IMSR)
No mouse lines available in IMSR.
See publication links below for author information.
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• 80% die between 10-12 weeks of age and by 16 weeks of age, 95% die (J:63300)
• 80% die between 10-12 weeks of age and by 16 weeks of age, 95% die (J:63300)
• 95% of mice die by 16 weeks of age with multicentric T-cell lymphomas (J:96010)
• 95% of mice die by 16 weeks of age with multicentric T-cell lymphomas (J:96010)

tumorigenesis
• tumor cell infiltration is seen in the liver, lungs, kidney, bone marrow and peripheral blood, indicating leukemic phase of the disease (J:63300)
• tumor cell infiltration is seen in the liver, lungs, kidney, bone marrow and peripheral blood, indicating leukemic phase of the disease (J:63300)
• 95% of mice die by 16 weeks of age with multicentric T-cell lymphomas (J:96010)
• 95% of mice die by 16 weeks of age with multicentric T-cell lymphomas (J:96010)
• thymus, spleen, and lymph nodes show massive infiltration by a monotonous lymphoblastic cell population (J:63300)
• mutants develop aggressive multicentric T-cell lymphomas showing features of lymphoblastic lymphoma with high penetrance by 7 weeks of age (J:63300)
• tumors sustain characteristics of immature thymocytes, including expression of CD25, pTalpha, and activated NF-kappaB (J:63300)
• thymus, spleen, and lymph nodes show massive infiltration by a monotonous lymphoblastic cell population (J:63300)
• mutants develop aggressive multicentric T-cell lymphomas showing features of lymphoblastic lymphoma with high penetrance by 7 weeks of age (J:63300)
• tumors sustain characteristics of immature thymocytes, including expression of CD25, pTalpha, and activated NF-kappaB (J:63300)

behavior/neurological

immune system
• hyperplastic thymus is seen in some mutants at 5-6 weeks of age (J:63300)
• hyperplastic thymus is seen in some mutants at 5-6 weeks of age (J:63300)
• in 3 week old mutants, particularly the late double negative cells (J:63300)
• in 3 week old mutants, particularly the late double negative cells (J:63300)
• disruption of thymocyte differentiation; all thymocyte subsets express high levels of CD25 and are broadly distributed in the cortex and medulla of the thymus, indicating a failure to downregulate CD25 expression the occurs normally in double positive and single positive subsets after 17-18 dpc (J:63300)
• disruption of thymocyte differentiation; all thymocyte subsets express high levels of CD25 and are broadly distributed in the cortex and medulla of the thymus, indicating a failure to downregulate CD25 expression the occurs normally in double positive and single positive subsets after 17-18 dpc (J:63300)
• 5- to 6-fold increase in size and weight of spleen at 5-6 weeks of age (J:63300)
• 5- to 6-fold increase in size and weight of spleen at 5-6 weeks of age (J:63300)
• 5- to 6-fold increase in size and weight of peripheral (axillary, cervical, and abdominal) lymph nodes at 5-6 weeks of age (J:63300)
• 5- to 6-fold increase in size and weight of peripheral (axillary, cervical, and abdominal) lymph nodes at 5-6 weeks of age (J:63300)

hematopoietic system
• hyperplastic thymus is seen in some mutants at 5-6 weeks of age (J:63300)
• hyperplastic thymus is seen in some mutants at 5-6 weeks of age (J:63300)
• in 3 week old mutants, particularly the late double negative cells (J:63300)
• in 3 week old mutants, particularly the late double negative cells (J:63300)
• disruption of thymocyte differentiation; all thymocyte subsets express high levels of CD25 and are broadly distributed in the cortex and medulla of the thymus, indicating a failure to downregulate CD25 expression the occurs normally in double positive and single positive subsets after 17-18 dpc (J:63300)
• disruption of thymocyte differentiation; all thymocyte subsets express high levels of CD25 and are broadly distributed in the cortex and medulla of the thymus, indicating a failure to downregulate CD25 expression the occurs normally in double positive and single positive subsets after 17-18 dpc (J:63300)
• 5- to 6-fold increase in size and weight of spleen at 5-6 weeks of age (J:63300)
• 5- to 6-fold increase in size and weight of spleen at 5-6 weeks of age (J:63300)

endocrine/exocrine glands
• hyperplastic thymus is seen in some mutants at 5-6 weeks of age (J:63300)
• hyperplastic thymus is seen in some mutants at 5-6 weeks of age (J:63300)
• in 3 week old mutants, particularly the late double negative cells (J:63300)
• in 3 week old mutants, particularly the late double negative cells (J:63300)

Mouse Models of Human Disease
OMIM ID Ref(s)
Leukemia, Acute Lymphoblastic; ALL 613065 J:63300





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Tumor Biology (MTB), Gene Ontology (GO), MouseCyc
Citing These Resources
Funding Information
Warranty Disclaimer & Copyright Notice
Send questions and comments to User Support.
last database update
02/02/2016
MGI 6.02
The Jackson Laboratory